Soluble mesothelin related protein in mesothelioma

被引：22

作者：

Creaney, Jenette

Christansen, Hanne

Lake, Richard

Musk, A. Bill

de Klerk, Nick

Robinson, Bruce W. S.

机构：

[1] Univ Western Australia, Sir Charles Gairdiner Hosp, Sch Med & Pharmacol, Nedlands, WA 6009, Australia

[2] Univ Western Australia, Sir Charles Gairdiner Hosp, Dept Resp Med, Nedlands, WA 6009, Australia

[3] Queen Elizabeth II Med Ctr, Western Australian Inst Med Res, Nedlands, WA, Australia

[4] Telethon Inst Child Hlth Res, Biostat & Epidemiol Unit, Subiaco, WA, Australia

来源：

JOURNAL OF THORACIC ONCOLOGY | 2006年 / 1卷 / 02期

关键词：

D O I：

10.1097/01243894-200602000-00013

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：172 / 174

页数：3

共 14 条

[11] Medical progress - Advances in malignant mesothelioma [J].

Robinson, BWS ;

Lake, RA .

NEW ENGLAND JOURNAL OF MEDICINE, 2005, 353 (15) :1591-1603

[12] Soluble member(s) of the mesothelin/megakaryocyte potentiating factor family are detectable in sera from patients with ovarian carcinoma [J].

Scholler, N ;

Fu, N ;

Yang, Y ;

Ye, ZM ;

Goodman, GE ;

Hellström, KE ;

Hellström, I .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (20) :11531-11536

[13]

Sturgeon C, 2002, CLIN CHEM, V48, P1151

[14] Resection margins, extrapleural nodal status, and cell type determine postoperative long-term survival in trimodality therapy of malignant pleural mesothelioma: Results in 183 patients [J].

Sugarbaker, DJ ;

Flores, RM ;

Jaklitsch, MT ;

Richards, WG ;

Strauss, GM ;

Carson, JM ;

DeCamp, MM ;

Swanson, SJ ;

Bueno, R ;

Lukanich, JM ;

Baldini, EH ;

Mentzer, SJ .

JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 1999, 117 (01) :54-63

← 1 2 →